Acquisition by Gregory Oakes of 54454 shares of Landos Biopharma subject to Rule 16b-3
| LABPDelisted Stock | USD 4.02 0.15 3.60% |
Slightly above 62% of Landos Biopharma's investor base is looking to short. The analysis of current outlook of investing in Landos Biopharma suggests that many traders are alarmed regarding Landos Biopharma's prospects. Landos Biopharma's investing sentiment overview a quick insight into current market opportunities from investing in Landos Biopharma. Many technical investors use Landos Biopharma stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Landos |
Filed transaction by Landos Biopharma Director, Officer: Chief Executive Officer. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Read at macroaxis.com
Landos Biopharma Fundamental Analysis
We analyze Landos Biopharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Landos Biopharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Landos Biopharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Probability Of Bankruptcy
Probability Of Bankruptcy Comparative Analysis
Landos Biopharma is currently under evaluation in probability of bankruptcy category among its peers. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
Landos Biopharma Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Landos Biopharma stock to make a market-neutral strategy. Peer analysis of Landos Biopharma could also be used in its relative valuation, which is a method of valuing Landos Biopharma by comparing valuation metrics with similar companies.
Peers
Landos Biopharma Related Equities
| XBIO | Xenetic Biosciences | 2.19 | ||||
| APLM | Apollomics | 0.00 | ||||
| CDIO | Cardio Diagnostics | 3.23 | ||||
| RNAZ | Transcode Therapeutics | 10.53 |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Consideration for investing in Landos Stock
If you are still planning to invest in Landos Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Landos Biopharma's history and understand the potential risks before investing.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |